Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.0001 par value per share, of Journey Medical Corporation and further agree to the filing of this agreement as an exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G.
Date: November 29, 2024 | TANG CAPITAL
PARTNERS, LP |
|||
By: | Tang Capital Management, LLC | |||
Its: | General Partner | |||
By: | /s/ Kevin Tang | |||
Name: | Kevin Tang | |||
Title: | Manager | |||
TANG CAPITAL
PARTNERS III, INC |
||||
By: | /s/ Kevin Tang | |||
Name: | Kevin Tang | |||
Title: | Chief Executive Officer | |||
TANG CAPITAL
PARTNERS IV, INC |
||||
By: | /s/ Kevin Tang | |||
Name: | Kevin Tang | |||
Title: | Chief Executive Officer | |||
TANG CAPITAL MANAGEMENT, LLC |
||||
By: | /s/ Kevin Tang | |||
Name: | Kevin Tang | |||
Title: | Manager | |||
/s/ Kevin Tang | ||||
Name: | Kevin Tang |